NCT00719225 A Belatacept Compassionate Use Study for Patients With a Kidney Transplant Status NO_LONGER_AVAILABLE Phase N/A
NCT00716456 Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib Status COMPLETED Phase PHASE1/PHASE2
NCT00716352 Prospective Registry of Outcomes and Management of Acute Ischaemic Syndromes Status COMPLETED Phase NA
NCT00714961 Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction Status COMPLETED Phase PHASE3
NCT00707590 Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) Status TERMINATED Phase PHASE1
NCT00706641 Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder Status COMPLETED Phase NA
NCT00705367 Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg Status COMPLETED Phase PHASE1
NCT00704106 Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders Status COMPLETED Phase N/A
NCT00703469 A Study of MDX-1106 to Treat Patients With Hepatitis C Infection Status COMPLETED Phase PHASE1
NCT00699790 Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance Status COMPLETED Phase PHASE2
NCT00698932 Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control Status COMPLETED Phase PHASE3
NCT00696072 Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic Status COMPLETED Phase PHASE2
NCT00694603 Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy Status TERMINATED Phase PHASE2
NCT00683852 A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy Status COMPLETED Phase PHASE3
NCT00680745 Efficacy and Safety of Dapagliflozin in Combination With Glimepiride (a Sulphonylurea) in Type 2 Diabetes Patients Status COMPLETED Phase PHASE3